16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008

Journal of the American College of Cardiology

Volumn 58, Issue 10, 2011, Pages 1001-1006

  Greenspon, Arnold J ^a   Patel, Jasmine D ^b,c   Lau, Edmund ^b,c   Ochoa, Jorge A ^c   Frisch, Daniel R ^a   Ho, Reginald T ^a   Pavri, Behzad B ^a   Kurtz, Steven M ^b,c  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b DREXEL UNIVERSITY   (United States)

^c Department of Biomedical Engineering Exponent ^*  (United States)

Author keywords

endocarditis; ICDs; infection; pacemakers

Indexed keywords

ARTICLE; ARTIFICIAL HEART PACEMAKER; COMORBIDITY; DEFIBRILLATOR; DEVICE INFECTION; DIABETES MELLITUS; HEART FAILURE; HOSPITALIZATION COST; HUMAN; INFECTION RATE; KIDNEY FAILURE; LENGTH OF STAY; MORTALITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; UNITED STATES;

COMORBIDITY; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PACEMAKER, ARTIFICIAL; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 80052087661     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.04.033     Document Type: Article

References (21)

1. S.M. Kurtz, J.A. Ochoa, and E. Lau Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993-2006 Pacing Clin Electrophysiol 33 2010 705 711
2. H.G. Mond, M. Irwin, H. Ector, and A. Proclemer The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2005: an International Cardiac Pacing and Electrophysiology Society (ICPES) project Pacing Clin Electrophysiol 31 2008 1202 1212
3. D.Z. Uslan, I.M. Tleyjeh, L.M. Baddour, J.L. St Sauver, and D.L. Hayes Temporal trends in permanent pacemaker implantation: a population study Am Heart J 155 2008 896 903
4. R.J. Myerburg Implantable cardioverter-defibrillators after myocardial infarction N Engl J Med 359 2008 2245 2253
5. G.H. Bardy, K.L. Lee, and D.B. Mark Sudden cardiac death in heart failure trial (SCD-HeFT) Amiodarone or an implantable defibrillator for congestive heart failure N Engl J Med 352 2005 225 237 (Pubitemid 40110811)
6. A.J. Moss, W. Zareba, W.J. Hall Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883 (Pubitemid 34984635)
7. R.O. Darouiche Treatment of infections associated with surgical implants N Engl J Med 350 2004 1422 1429 (Pubitemid 38419996)
8. M.R. Sohail, D.Z. Uslan, and A.H. Khan Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections J Am Coll Cardiol 49 2007 1851 1859 (Pubitemid 46661104)
9. L.M. Baddour, A.E. Epstein, and C.C. Erickson Update on cardiovascular implantable electronic device infections and their management A scientific statement from the American Heart Association Circulation 121 2010 458 477
10. C.H. Cabell, P.A. Heidenreich, and V.H. Chu Increasing rates of cardiac device infections among Medicare beneficiaries: 19901999 Am Heart J 147 2004 582 586 (Pubitemid 38900441)
11. A. Voigt, A. Shalaby, and S. Saba Continued rise in rates of cardiovascular implantable device infection in the United States: temporal trends and causative insights Pacing Clin Electrophysiol 33 2010 414 419
12. M.B. McClellan, and S.R. Tunis Medicare coverage of ICDs N Engl J Med 352 2005 222 224 (Pubitemid 40110810)
13. S.M. Al-Khatib, J.G. Lucas Jollis, D.J. Malenka, and D.E. Wennberg The relation between patients' outcome and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries J Am Coll Cardiol 46 2005 1536 1540 (Pubitemid 41446191)
14. P.N. Peterson, S.L. Daugherty, and Y. Wand Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy Circulation 119 2009 1078 1084
15. J.P. Curtis, J.J. Luebbert, and Y. Wang Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator JAMA 301 2009 1661 1670
16. P.B. Nery, B. Fernandes, and G.M. Nair Device-related infection among patients with pacemakers and implantable defibrillators: incidence, risk factors, and consequences J Cardiovasc Electrophysiol 21 2010 786 790
17. D.Z. Uslan, M.R. Sohail, and J.L. St Sauver Permanent pacemaker and implantable cardioverter-defibrillator infection A population-based study Arch Intern Med 167 2007 669 675 (Pubitemid 46598459)
18. T.B. Ferguson Jr., C.L. Ferguson, K. Crites, and P. Crimmins-Reda The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations J Thorac Cardiovasc Surg 111 1996 742 775
19. C.J.M. Borleffs, J. Thijssen, and M.K. De Bie Recurrent implantable cardioverter-defibrillator replacement is associated with an increasing risk of pocket-related complications Pacing Clin Electrophysiol 33 2010 1013 1019
20. J.E. Poole, M.J. Gleva, T. Mela REPLACE Registry Investigators Complication rates associated with pacemaker or implantable cardioverter- defibrillator replacements and upgrade procedures: results from the REPLACE registry Circulation 122 2010 1553 1561
21. A. Dasgupta, J. Montalvo, and S. Medendorp Increased complication rates of cardiac rhythm management devices in ESRD patients Am J Kidney Dis 49 2007 656 663 (Pubitemid 46654496)